Logo image of AQST

AQUESTIVE THERAPEUTICS INC (AQST) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:AQST - US03843E1047 - Common Stock

6.45 USD
-0.01 (-0.15%)
Last: 1/2/2026, 8:00:01 PM
6.4876 USD
+0.04 (+0.58%)
After Hours: 1/2/2026, 8:00:01 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
AQST revenue by date.AQST revenue by date.
47.68M
-6.20%
50.583M
6.09%
57.561M
13.80%
45.76M
-20.50%
69.709M
52.34%
115.68M
65.95%
175.66M
51.85%
244.37M
39.12%
369.28M
51.12%
438.91M
18.86%
584.36M
33.14%
EBITDA
YoY % growth
AQST ebitda by date.AQST ebitda by date.
-39.68M
-25.09%
-13.757M
65.33%
-30.053M
-118.46%
-48.589M
-61.68%
-57.815M
-18.99%
-16.218M
71.95%
40.086M
347.17%
83.385M
108.02%
173.2M
107.71%
217.16M
25.38%
N/A
EBIT
YoY % growth
AQST ebit by date.AQST ebit by date.
-42.07M
-21.31%
-15.102M
64.10%
-30.771M
-103.75%
-55.378M
-79.97%
-56.328M
-1.72%
-18.084M
67.90%
32.692M
280.78%
88.67M
171.23%
166.65M
87.94%
143.21M
-14.07%
253.88M
77.28%
Operating Margin
AQST operating margin by date.AQST operating margin by date.
-88.23%-29.86%-53.46%-121.02%-80.81%-15.63%18.61%36.29%45.13%32.63%43.45%
EPS
YoY % growth
AQST eps by date.AQST eps by date.
-1.14
23.49%
-0.36
68.42%
-0.52
-44.44%
-0.66
-26.76%
-0.56
15.56%
-0.17
68.85%
-0.02
88.24%
0.21
1,150.00%
N/AN/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.14
25.51%
-0.18
24.56%
-0.18
-27.50%
-0.16
-14.75%
-0.14
0.90%
Revenue
Q2Q % growth
13.609M
26.45%
11.858M
35.99%
14.088M
40.84%
18.208M
42.17%
22.501M
65.34%
EBITDA
Q2Q % growth
-13.158M
0.92%
-23.185M
-20.59%
-21.615M
-94.92%
-19.259M
-74.11%
-17.688M
-34.43%
EBIT
Q2Q % growth
-13.299M
5.01%
-20.823M
-7.53%
-19.732M
-73.58%
-18.605M
-62.08%
-17.463M
-31.31%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.14
-7.69%
-0.140.00-3.59%
Q2 2025
Q2Q % growth
-0.14
-366.67%
-0.170.0318.46%
Q1 2025
Q2Q % growth
-0.24
-41.18%
-0.17-0.07-38.41%
Q4 2024
Q2Q % growth
-0.19
-72.73%
-0.14-0.05-37.26%
Q3 2024
Q2Q % growth
-0.13
-333.33%
-0.130.00-0.62%
Q2 2024
Q2Q % growth
-0.03
70.00%
-0.130.1076.28%
Q1 2024
Q2Q % growth
-0.17
-41.67%
-0.08-0.09-102.44%
Q4 2023
Q2Q % growth
-0.11
52.17%
-0.08-0.03-34.80%
Q3 2023
Q2Q % growth
-0.03
86.96%
-0.120.0974.02%
Q2 2023
Q2Q % growth
-0.10
72.22%
-0.120.0216.92%
Q1 2023
Q2Q % growth
-0.12
62.50%
-0.190.0737.75%
Q4 2022
Q2Q % growth
-0.23
39.47%
-0.240.012.30%
Q3 2022
Q2Q % growth
-0.23
37.84%
-0.320.0927.73%
Q2 2022
Q2Q % growth
-0.36
-9.09%
-0.370.011.96%
Q1 2022
Q2Q % growth
-0.32
21.95%
-0.420.1023.11%
Q4 2021
Q2Q % growth
-0.38
36.67%
-0.480.1020.31%
Q3 2021
Q2Q % growth
-0.37
24.49%
-0.460.0919.39%
Q2 2021
Q2Q % growth
-0.33
-371.43%
-0.450.1226.13%
Q1 2021
Q2Q % growth
-0.41
16.33%
-0.430.025.64%
Q4 2020
Q2Q % growth
-0.60 -0.27-0.33-126.24%
Q3 2020
Q2Q % growth
-0.49 -0.47-0.02-5.35%
Q2 2020
Q2Q % growth
-0.07 -0.440.3784.11%
Q1 2020
Q2Q % growth
-0.49 -0.48-0.01-3.09%
AQST Yearly EPS VS EstimatesAQST Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 -0.5 -1 -1.5 -2 -2.5
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
12.807M
-5.43%
13.202M-395K-2.99%
Q2 2025
Q2Q % growth
10.003M
-50.23%
11.546M-1.543M-13.36%
Q1 2025
Q2Q % growth
8.72M
-27.65%
12.475M-3.755M-30.10%
Q4 2024
Q2Q % growth
10.762M
-2.15%
13.345M-2.583M-19.36%
Q3 2024
Q2Q % growth
13.542M
18.70%
12.937M605K4.68%
Q2 2024
Q2Q % growth
20.099M
51.79%
12.628M7.471M59.16%
Q1 2024
Q2Q % growth
12.053M
8.25%
12.508M-455K-3.64%
Q4 2023
Q2Q % growth
10.998M
2.98%
11.864M-866K-7.30%
Q3 2023
Q2Q % growth
11.409M
-0.45%
11.744M-335K-2.85%
Q2 2023
Q2Q % growth
13.241M
-0.22%
11.232M2.009M17.89%
Q1 2023
Q2Q % growth
11.134M
-9.26%
10.136M998K9.85%
Q4 2022
Q2Q % growth
10.68M
-3.61%
10.625M55K0.52%
Q3 2022
Q2Q % growth
11.46M
-13.77%
11.258M202K1.79%
Q2 2022
Q2Q % growth
13.27M
-13.55%
10.784M2.486M23.05%
Q1 2022
Q2Q % growth
12.27M
10.34%
10.313M1.957M18.98%
Q4 2021
Q2Q % growth
11.08M
54.97%
9.549M1.531M16.03%
Q3 2021
Q2Q % growth
13.29M
60.90%
11.234M2.056M18.30%
Q2 2021
Q2Q % growth
15.35M
-29.20%
9.665M5.685M58.82%
Q1 2021
Q2Q % growth
11.12M
26.80%
9.147M1.973M21.57%
Q4 2020
Q2Q % growth
7.15M 6.377M773K12.12%
Q3 2020
Q2Q % growth
8.26M 8.897M-637K-7.16%
Q2 2020
Q2Q % growth
21.68M 8.941M12.739M142.48%
Q1 2020
Q2Q % growth
8.77M 10.274M-1.504M-14.64%
AQST Yearly Revenue VS EstimatesAQST Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M 400M 500M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-0.7% 4.31% -0.28% -0.11%
Revenue-0.03% -1.57% -0.01% -0.19%